Literature DB >> 25973887

Surgical Interventions for Pediatric Unilateral Vocal Cord Paralysis: A Systematic Review.

Oleksandr Butskiy1, Bhavik Mistry2, Neil K Chadha1.   

Abstract

IMPORTANCE: The most widely used surgical interventions for pediatric unilateral vocal cord paralysis include injection laryngoplasty, thyroplasty, and laryngeal reinnervation. Despite increasing interest in surgical interventions for unilateral vocal cord paralysis in children, the surgical outcomes data in children are scarce.
OBJECTIVE: To appraise and summarize the available evidence for pediatric unilateral vocal cord paralysis surgical strategies. EVIDENCE REVIEW: MEDLINE (1946-2014) and EMBASE (1980-2014) were searched for publications that described the results of laryngoplasty, thyroplasty, or laryngeal reinnervation for pediatric unilateral vocal cord paralysis. Further studies were identified from bibliographies of relevant studies, gray literature, and annual scientific assemblies. Two reviewers independently appraised the selected studies for quality, level of evidence, and risk of bias as well as extracted data, including unilateral vocal cord paralysis origin, voice outcomes, swallowing outcomes, and adverse events.
FINDINGS: Of 366 identified studies, the inclusion criteria were met by 15 studies: 6 observational studies, 6 case series, and 3 case reports. All 36 children undergoing laryngeal reinnervation (8 studies) had improvement or resolution of dysphonia. Of 31 children receiving injection laryngoplasty (6 studies), most experienced improvement in voice quality, speech, swallowing, aspiration, and glottic closure. Of 12 children treated by thyroplasty (5 studies), 2 experienced resolution of dysphonia, 4 had some improvement, and 4 had no improvement (2 patients had undocumented outcomes). Thyroplasty resolved or improved aspiration in 7 of 8 patients. CONCLUSIONS AND RELEVANCE: Published studies suggest that reinnervation may be the most effective surgical intervention for children with dysphonia; however, long-term follow-up data are lacking. With the exception of polytetrafluoroethylene injections, injection laryngoplasty was reported to be a relatively safe, nonpermanent, and effective option for most children with dysphonia. Thyroplasty appears to have fallen out favor in recent years because of difficulty in performing this procedure in children under local anesthesia, but it continues to be a viable option for children with aspiration.

Entities:  

Mesh:

Year:  2015        PMID: 25973887     DOI: 10.1001/jamaoto.2015.0680

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  5 in total

1.  Laryngeal reinnervation for paediatric vocal cord palsy: a systematic review.

Authors:  Andrew W Hoey; Andrew Hall; Colin Butler; Claire Frauenfelder; Michelle Wyatt
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-15       Impact factor: 3.236

2.  Bilateral Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis in Children.

Authors:  Janet W Lee; Nicolas Bon-Mardion; Marshall E Smith; Jean-Paul Marie
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-05-01       Impact factor: 6.223

3.  Exercise Induced Laryngeal Obstruction in Humans and Equines. A Comparative Review.

Authors:  Zoe Louise Fretheim-Kelly; Thomas Halvorsen; Hege Clemm; Ola Roksund; John-Helge Heimdal; Maria Vollsæter; Constanze Fintl; Eric Strand
Journal:  Front Physiol       Date:  2019-10-30       Impact factor: 4.566

4.  Effect of injection laryngoplasty material on outcomes in pediatric vocal fold paralysis.

Authors:  Ryan Bishop; Marike Mousset; Abdulrahman Althubaiti; Austin Gerwig; Charlemagne Kern; Amanda Onwuka; Rishabh Sethia; Tendy Chiang; Charles Elmaraghy
Journal:  Transl Pediatr       Date:  2022-07

5.  Non-selective laryngeal reinnervation in a child with unilateral left vocal fold palsy utilizing laryngeal electromyography.

Authors:  Morad Faoury; Steven Frampton; David Allen; Andrea Burgess; Kate Heathcote; Hasnaa Ismail-Koch
Journal:  J Surg Case Rep       Date:  2019-02-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.